Clotrimazole and efaroxan inhibit red cell Gardos channel independently of imidazoline I1 and I2 binding sites

This publication has 11 references indexed in Scilit:

• Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors
  European Journal of Pharmacology, 1994
• Sodium excretion following central administration of an I₁ imidazoline receptor agonist, moxonidine
  British Journal of Pharmacology, 1994
• The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I₁‐ and I₂‐sites
  British Journal of Pharmacology, 1994
• Treatment with oral clotrimazole blocks Ca(2+)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease.
  Journal of Clinical Investigation, 1994
• Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives.
  Journal of Clinical Investigation, 1993
• Characterization and autoradiographical localization of non‐adrenoceptor idazoxan binding sites in the rat brain
  British Journal of Pharmacology, 1992
• Keeping an eye on the I site: imidazoline-prefemng receptors
  Trends in Pharmacological Sciences, 1992
• The imidazoline preferring receptor: binding studies in bovine, rat and human brainstem
  European Journal of Pharmacology, 1989
• [3H]Idazoxan binding at non-α2-adrenoceptors in rabbit adipocyte membranes
  European Journal of Pharmacology, 1989
• Cation permeability alterations during sickling: relationship to cation composition and cellular hydration of irreversibly sickled cells
  Blood, 1978